SCYNEXIS, Inc.

• SCYNEXIS, Inc. Estimates – NASDAQ:SCYX
  TradingView · 23 Oct 2026
• SCYNEXIS (SCYX) Reports Positive Phase 1 Data for SCY-247 Antifu
  GuruFocus · 22 Oct 2026
• SCYNEXIS reports phase 1 results for IV antifungal SCY-247 By Investing.com
  Investing.com India · 22 Oct 2026
• SCYNEXIS will present a candidate that may act against drug-resistant fungi
  Stock Titan · 21 Oct 2026
• SCYNEXIS completes phase 1 study of SCY-770 for kidney disease
  Investing.com India · 06 Oct 2026
• SCYNEXIS Inc. (SCYX) Edges Up 0.87% to $4.66 as Shares Hold Above Key Support - Naked POC
  https://www.siam.in/ · 29 Sep 2026
• Scynexis bags $214M BARDA contract for antifungal development
  Fierce Biotech · 28 Sep 2026
• Scynexis stock surges on $214M BARDA contract for SCY-247
  Investing.com · 28 Sep 2026
• BARDA awards Scynexis up to $214M to advance antifungal
  FirstWord Pharma · 28 Sep 2026
• SCYNEXIS Wins BARDA Contract Worth Up to $214 Million for SCY-247
  citybiz · 28 Sep 2026
• Why is Scynexis stock surging today?
  Investing.com · 28 Sep 2026
• SCYNEXIS secures BARDA contract for antifungal development By Investing.com
  Investing.com UK · 28 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →